| Tag | Content |
|---|
EnhancerAtlas ID | HS162-01886 |
Organism | Homo sapiens |
Tissue/cell | Plasma_cell_myeloma |
Coordinate | chr11:62229130-62231290 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| JUN(var.2) | MA0489.1 | chr11:62229422-62229436 | AATAAATGAGTCAT | + | 6.03 | | JUN(var.2) | MA0489.1 | chr11:62229427-62229441 | ATGAGTCATTTTAT | - | 6.23 | | Klf1 | MA0493.1 | chr11:62229799-62229810 | GGCCACACCCA | + | 6.62 | | NR2C2 | MA0504.1 | chr11:62229717-62229732 | TGACCTCCGCCCTCC | - | 6.02 | | RREB1 | MA0073.1 | chr11:62229673-62229693 | CCCCACCCCAACGCCCACCC | + | 6.45 | | ZNF263 | MA0528.1 | chr11:62230913-62230934 | CGCTCCTCTCCTCCATCCTCC | - | 6.86 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09961 | chr11:62228696-62231560 | CD14 | | SE_47222 | chr11:62228705-62230890 | Panc1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr11 | 62230737 | 62230901 | | chr11 | 62229160 | 62230410 | | chr11 | 62230567 | 62231178 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH11I062461 | chr11 | 62229207 | 62230357 | | GH11I062463 | chr11 | 62230505 | 62231215 |
|
Enhancer Sequence | TACTAAAAAT ATGAAGAGTA GCTGTGTATG GTGGTGTATG CCTGTAATCC CAGCTACTCG 60
GGAGGCTGAG GCAGGAGAAT CACTTGAACC CGGGAGGCGG AGGTTGCGGT GAGCCGAGAT 120
GGCGCCATTG CACTCCAGCC TGGGCAACAG AGCGAAACGA CATCTCAAAA AAAAAAAAAA 180
AAACAACCTT CCACAGGATA GTTCACGGCA AAATGGGAAC AATCTTCCAG GAACTGATGT 240
CTTTGTGGTT GGCCCAGGAA AAAAATACCA TGGCCATGTG GAATCCTTGG GGAATAAATG 300
AGTCATTTTA TAGGGAAGAA TTTCCTGAAT AGCTGAAGGT GAAACCTTTA TGAGATGGGC 360
ATTTAAACTT TTAAATAGAA GTCCTTCTAA AATGGCCTCT TGGCCCCTGC ATTTTAAAAC 420
ACAGCACAAG GCACATTATT TCAGCAATCT CATTTTTAAG GTGGCACCCT AGAGCCTGCT 480
GGCACCTGGA ACTCCTCTTG TCAGCGTCTT ACCTTCCCAA CTTTCCCTCT CTCACCACAG 540
TCCCCCCACC CCAACGCCCA CCCTCCACCC GCTGGGCCTC CGCCACCTGA CCTCCGCCCT 600
CCCATCTCAT CTCAACTCTC TGGTCCTGCC TCAGCCCTCT TTAGCACTGA CAGTTATTCA 660
AAGCTCAGCG GCCACACCCA GTGGATCAGC AGTTTTCTGT CTCTATTTGT GAAAGCTACA 720
GAACTGGAAA CTACTGAAGA CTGTCCCAGA ACCAGGCTGT GGATAATTAC AGCAACAGGC 780
AACGTTCCTT TGCCACAGGA CACTTGATTT ACATATTTTA TGAAGTCCTT ACACCCTCAA 840
AAGCAGCCAA GCACAGGTGG TTTTAGCCAC ATTTTTATGA CGAAACTAAG TTTTACAGGT 900
TAGATGAGCT TTGAAGGGGC ACCTGGTTGA TAAACGGTAG ATAGATAACT TAATCCAGAT 960
CTTCTAACGC TAAATCCACA CACGTTGCTA CTTCTTGAAT CACCTAATCT TAAGGATCAG 1020
TTATCTAAAA TCGCCCAGAA AATGGGCAGA AGGAGTGACA GTTGATTATC TGGTTACAAA 1080
GGGTTTCGAC AATGTGACTG GTCTGGATGT CATTGTTAAT AGCCCTTAGT AGAAGAAATA 1140
GATGAGGATG GAGGAGCTTT GTTAATTTAG TTTCAGAAGA GTTGGCTTCA GGCCGGGTGC 1200
GGTGGCTCAC GCCTATGATC CCAGCACTTT GGGAGGCTGA GGCAGGCCAG TCACCTGAGG 1260
TCAGGAGTTT GAGACCAGCC TGGTCAACAT GGAGAAACCC CGTCTCTACT AAAAATACAA 1320
AAATTAGCCG GGCGTGGTGC CTGTAATCCC AGCTACTCGG GAGGCTGAGG CAGGAGAATC 1380
ACTTGAACCC AGGAAGCAGA GGTTGCAGTG AGGCGAGATC GTGCCCCTGC ACTCCAGCCT 1440
GGGCGACAGA GCCAGACTCA GTCTCAAAAA AAAAAAAAAA AAAAAAAGAG TTGGCTTCTG 1500
CTATCTCCAT CTGCCAGTCC TACAGACCAG GAATGTGTTT CTAACAATGT ATCCATTTTA 1560
ACCATATTCC AGGACAACAA GCAGTGTCTT CTGTTCCAAT AAGTTGATTA TAACAGGATG 1620
CTGGCAGTTT GGCTCTTTGC AGAGAGTACA CACCCCACAC TCACGCAAAC TGGCGTCACT 1680
TTAAATTTGT GACCACAGAT CTCAAGTTGC CACCCAGCAC TGCCCGGAAA TGCTGCTGCA 1740
TTTCTTAGCA AATTCGCCTG TCCCTTTTTC AAGATGACTG CTCCGCTCCT CTCCTCCATC 1800
CTCCAGCCTC CAGCCTCCAG CCTCCAGCCT CCCTCCCGTC TTGCTTTCAG TTCATGATTT 1860
TGCCTTGTGC ACCAAGAAAA ATTAAGCCAT GATCAAGAGC TAGCTCATCT TCCCTCCATC 1920
AACACTTCCA TTTCCCTACA TCCCACTGTG CGTGCTGTCA GGCCTGTTCT GCTGACAGGG 1980
TGACCGACTG TCCTGGTTTG CCTGGAACTG AGGGGGTTCC TGGGGTATGG AACTTGCTGG 2040
GTTTTTGGTT TTGGTTGTTT TTTTGTTTGT TTGGTTGGTT GGTTGGTTTG TTTTGGGTTT 2100
TGTTTTTGTT TTTGTTTTTT TGGGAGACAG AGTCTTGCTC TATCCCCCAG GCTGGAGTGC 2160
|
